Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes

Sutter Health

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Behavioral: Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01715649

1208042ex

Details and patient eligibility

About

Telehealth remote patient monitoring is a means of using communications technology - such as telephones, computers, and the Internet - to connect patients remotely with their healthcare team from their homes. The investigators hope to learn more about improving healthy behaviors and blood glucose among persons with diabetes using telehealth remote patient monitoring technology to connect directly with nurse care coordinators.

The purpose of this study is to evaluate a process for improving blood glucose and healthy behaviors among people with type 2 diabetes using telehealth remote patient monitoring technology with nurse care coordinators. Some of the people in this study will work with a nurse care coordinator who will review your blood glucose weekly and call you at home every month for 3 months, while some of the people in this study will simply receive their normal care. At the end of the study, every participant will be asked questions about how they feel about their health care.

Enrollment: 90 patients

Sex: All

Ages: 30 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Enrolled in diabetes disease management program
• ages 30-70
• HbA1c between 7.5% and 10.9% in the previous six months
• an Internet or 3G connection and email address;
• a working phone line (land line or cellular); and
• ability to read and understand the English language.

Exclusion criteria

• taking insulin;
• inability to independently engage in self-management behaviors (diagnosis of dementia, severe depression, schizophrenia, or cognitive impairment);
• severe complications, which would preclude achieving an HbA1c goal of 7% including diagnosis of the following:
• severe stroke;
• heart failure;
• end-stage renal disease;
• kidney dialysis; and
• legally blind.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

90 participants in 2 patient groups

Control-usual care

No Intervention group

Description:

Nurse care coordination in a telephonic diabetes disease management program

Intervention paired testing and remote monitoring

Experimental group

Description:

Telehealth remote patient monitoring, structured blood glucose and usual care Paired testing-weekly remote monitoring Data analysis Virtual visits in EHR

Treatment:

Behavioral: Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose